MedTrace inaugurates U.S. headquarters in downtown Minneapolis

MedTrace inaugurates U.S. headquarters in downtown Minneapolis Danish-born MedTrace is opening its new U.S. headquarters in Minneapolis’ IDS Center on September 7, 2022. The company expects to grow from 4 to 10 US-based employees within the next 12 months, and co-founder and COO Rune Wiik Kristensen will add “U.S. President” to his title when he […]

MedTrace Announces First Subject Scanned in Phase 3 Clinical Trial

MedTrace Pharma Announces First Subject Scanned in the Company’s RAPID-WATER-FLOW Phase 3 Clinical Trial First Subject Scanned in RAPID-WATER-FLOW Trial at Aarhus University Hospital, Denmark Multiple Sites Involved Across the United States, Denmark, Sweden, and The Netherlands The Global Trial is Expected to Continue for 12 Months MedTrace Pharma A/S, a pharma and device company […]

MedTrace expands management with financial strategist as CFO

MedTrace expands management and appoints financial strategist heavyweight as CFO Ann Kristin Led, former Exec. Vice President of Finance and Strategy at pharma company MC2 Therapeutics, is the new CFO at MedTrace from April 1. She will join CEO Martin Stenfeldt and COO Rune Wiik Kristensen as part of management and play a vital role […]

MedTrace announces IND approval of RAPID-WATER phase 3 clinical trial

MedTrace Pharma announces IND approval with the initiation of RAPID-WATER phase 3 clinical trial MedTrace Pharma A/S announced today the FDA approval of the company’s Investigational New Drug (IND) application and the approval to commence the RAPID-WATER clinical trial to evaluate the use of 15O-water PET in diagnosing Coronary Artery Disease (CAD). The global trial […]

MedTrace Pharma takes step towards CE marking

MedTrace Pharma takes step towards CE marking A notified body has signed a contract to review MedTrace Pharma’s aQuant software and patient kit products with an eye to CE marking. The notified body, BSI, is based in the Netherlands. “We’re encouraged that BSI has agreed to audit our products,” says Rune Wiik Kristensen of MedTrace […]

MedTrace Installs P3 System at Sahlgrenska University Hospital

MedTrace Installs P3 System at Sahlgrenska University Hospital MedTrace Pharma A/S has signed a contract with Sahlgrenska University Hospital in Gothenburg, Sweden for the installation of a new P3 production and infusion system providing up to 1000 doses of 15O-water per year for the next five years. The Gothenburg-based hospital, one of the largest in […]

Investors inject $30 million into Danish medical imaging company

Investors inject $30 million into Danish medical imaging company Swiss-based Swisscanto Invest and Danish investors ATP and BankInvest are the main investors injecting nearly $30 million into MedTrace, a company specialized in diagnosis of heart diseases. The fresh capital is a significant step forward in the company’s plan to expand into the USA as well […]

First patient imaged with MedTrace technology

First patient imaged with MedTrace technology The first PET scans with 15O-water generated with a novel production and administration system from the Danish company MedTrace Pharma A/S (MedTrace) have been performed in patients at Aarhus University Hospital (AUH).  AUH has become the first hospital in the world to utilize, under a magistral exemption, a clinical […]

MedTrace to partner with Mayo Clinic in oncology study

MedTrace to partner with Mayo Clinic in oncology study As part of the recently closed equity fundraising, MedTrace also signed a know-how license agreement with Mayo Clinic (Rochester, MN, USA) embarking on the already installed P3 prototype and the aQuant software. The scope of the agreement is outlined in the press release below. Press Release […]

MedTrace feature article in Børsen

MedTrace feature article in Børsen MedTrace is proud to see a feature article in Børsen (May 26th, 2020), Denmarks leading business newspaper. CEO Martin Stenfeldt was interviewed about the latest progress, the next steps and his view on market launch estimates as well as exit opportunities. The article requires a subscription to Børsen to access […]